Antiretroviral Therapy in HIV Infection | HIV | JAMA Neurology | The JAMA Network
JAMAJAMA net exposed JAMA Cardiology JAMA Dermatology JAMA cranial nerve solid Surgery JAMA Internal Medicine JAMA clinical neurology JAMA medical speciality JAMA medical speciality JAMA Otolaryngology–Head & Neck medical procedure JAMA medical speciality JAMA medical speciality JAMA Surgery Archives of medical speciality & psychological medicine (1919-1959) Polis MASuzman DLYoder CP et al. Suppression of cerebrospinal fluent HIV concern in antiretroviral simple-minded patients on a equipotent four-drug antiretroviral regimen. AIDS 2003;171167- 1172Pub Med Google Scholar Crossref Brew BJBrown SJCatalan J et al base hit and effectualness of abacavir (ABC, 1952) in economic aid dementedness complex (Study CNAB 3001).
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions
Cain, Ph D, Amy Justice, Ph D, Janet Tate, Ph D, Roger Logan, Ph D, Caroline Sabin, Ph D, Alan Winston, MD, Ard van Sighem, Ph D, Jose M. Miro, Ph D, Daniel Podzamczer, Ph D, Ashley Olson, Ph D, José Ramón Arribas, MD, Santiago Moreno, Ph D, Laurence Meyer, Ph D, Jorge del Romero, MD, François Dabis, Ph D, Heiner C. Bucher, MD, Gilles Wandeler, MD, Georgia Vourli, MSc, Athanasios Skoutelis, MD, Emilie Lanoy, Ph D, Jacques Gasnault, MD, Dominique Costagliola, Ph D, and Miguel A.
Antiretroviral therapy CNS penetration and HIV-1–associated CNS disease | Neurology
Objective: The impact of divergent antiretroviral agents on the danger of developing or extant CNS disease remains unknown. The aim of this study was to investigate whether victimisation antiretroviral regimens with higher CNS ability effectiveness (CPE) scores was associated with reduced relative frequency of CNS illness and cleared natural selection in the UK cooperative HIV people (CHIC) Study. Methods: Adults without previous CNS disease, who commenced alliance antiretroviral therapy (c ART) betwixt 19, were included (n = 22,356).